Abstract
贾鑫华,匡雪凤,陈亚涵,李煜霏,毕兆峰,吴婷,乔友林.人乳头瘤病毒疫苗长期保护效力研究进展[J].Chinese journal of Epidemiology,2023,44(5):851-854
人乳头瘤病毒疫苗长期保护效力研究进展
Progress in research of long-term protective efficacy of human papillomavirus vaccine
Received:October 25, 2022  
DOI:10.3760/cma.j.cn112338-20221025-00905
KeyWord: 宫颈癌  人乳头瘤病毒疫苗  效力  长期随访
English Key Word: Cervical cancer  Human papillomavirus vaccine  Efficacy  Long-term follow-up
FundProject:中国医学科学院医学与健康科技创新工程(2021-I2M-1-004)
Author NameAffiliationE-mail
Jia Xinhua The State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, Xiamen 361102, China
Department of Epidemiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences&
Peking Union Medical College, Beijing 100021, China 
 
Kuang Xuefeng The State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, Xiamen 361102, China
Department of Epidemiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences&
Peking Union Medical College, Beijing 100021, China 
 
Chen Yahan Yanjing Medical College, Capital Medical University, Beijing 101300, China  
Li Yufei The State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, Xiamen 361102, China
Department of Epidemiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences&
Peking Union Medical College, Beijing 100021, China 
 
Bi Zhaofeng The State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, Xiamen 361102, China  
Wu Ting The State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, Xiamen 361102, China  
Qiao Youlin The State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, Xiamen 361102, China
Center for Global Health, School of Population Medicine and Public Health, Chinese Academy of Medical Sciences&
Peking Union Medical College, Beijing 100730, China 
qiaoy@cicams.ac.cn 
Hits: 3604
Download times: 1363
Abstract:
      HPV疫苗对宫颈癌的预防作用已经在众多临床试验和真实世界中得到验证。其中试验人群的随访年限一般为5~6年。临床试验结束后,为了验证疫苗的长期有效性,部分地区开展了系列长期随访研究,本文检索了目前国内外对HPV疫苗长期保护效力相关研究。目前公开的数据显示对疫苗保护型别相关的宫颈上皮内瘤病变2级及以上保护效力均高于90%。
English Abstract:
      The efficacy of HPV vaccine in preventing cervical cancer has been demonstrated in numerous clinical trials and clinical uses. The follow-up after clinical trials usually last for 5-6 years to evaluate the long-term efficacy, and a series of long-term follow-up studies have been conducted in some regions. The literature retrieval of HPV vaccine long term efficiency research both at home and abroad indicated that the protective efficacy of the vaccine against vaccine-type-related cervical intraepithelial neoplasia grade 2 and above is higher than 90%.
View Fulltext   Html FullText     View/Add Comment  Download reader
Close